US 11027000
AADC polynucleotides for the treatment of Parkinson's disease
granted A61KA61K35/76A61K38/51
Quick answer
US patent 11027000 (AADC polynucleotides for the treatment of Parkinson's disease) held by VOYAGER THERAPEUTICS, INC. expires Mon Jun 03 2041 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- VOYAGER THERAPEUTICS, INC.
- Grant date
- Tue Jun 08 2021 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Jun 03 2041 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 26
- CPC classes
- A61K, A61K35/76, A61K38/51, A61K48/005, A61P